Showing results (361-370 of 370) with videos related to
Sort By:
Pageof 37
You have reached the last page of results.This site can display upto 370 results.
Proceedings of the National Academy of Sciences of the United States of America|August 20, 2025
Identification of broadly inhibitory anti-PfEMP1 antibodies by mass spectrometry sequencing of plasma IgG from a malaria-exposed childLouise Turner, Teresa Nunez de Villavicencio Diaz, Sai Sundar Rajan Raghavan, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 11, 2019
First-in-human, Randomized, Double-blind Clinical Trial of Differentially Adjuvanted PAMVAC, A Vaccine Candidate to Prevent Pregnancy-associated MalariaBenjamin Mordmüller, Mihály Sulyok, Diane Egger-Adam, et al.Biorxiv : the Preprint Server for Biology|February 8, 2024
Broadly inhibitory antibodies against severe malaria virulence proteinsRaphael A Reyes, Sai Sundar Rajan Raghavan, Nicholas K Hurlburt, et al.The Lancet. Microbe|January 21, 2023
First-in-human use of a modular capsid virus-like vaccine platform: an open-label, non-randomised, phase 1 clinical trial of the SARS-CoV-2 vaccine ABNCoV2Merel J Smit, Adam F Sander, Maud B P A Ariaans, et al.Nature|November 20, 2024
Broadly inhibitory antibodies to severe malaria virulence proteinsRaphael A Reyes, Sai Sundar Rajan Raghavan, Nicholas K Hurlburt, et al.Cancer Cell|October 14, 2015
Targeting Human Cancer by a Glycosaminoglycan Binding Malaria ProteinAli Salanti, Thomas M Clausen, Mette Ø Agerbæk, et al.Lab Animal|November 6, 2023
Aotus nancymaae model predicts human immune response to the placental malaria vaccine candidate VAR2CSAJustin Doritchamou, Morten A Nielsen, Arnaud Chêne, et al.Nature Communications|August 30, 2024
Tumor-agnostic cancer therapy using antibodies targeting oncofetal chondroitin sulfateElena Ethel Vidal-Calvo, Anne Martin-Salazar, Swati Choudhary, et al.Nature Communications|January 13, 2021
Capsid-like particles decorated with the SARS-CoV-2 receptor-binding domain elicit strong virus neutralization activityCyrielle Fougeroux, Louise Goksøyr, Manja Idorn, et al.The New England Journal of Medicine|November 10, 2012
A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants, Selidji Todagbe Agnandji, Bertrand Lell, et al.Pageof 37